You are here

Article info

Article menu

Download PDFPDF

Perspective
Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the ‘breakthrough’
Free

Authors

  • Martin Mayer Department of Physician Assistant Studies, East Carolina University, Greenville, North Carolina, USA Vidant Medical Center, Greenville, North Carolina, USA PubMed articlesGoogle scholar articles
  1. Correspondence to : Professor Martin Mayer
    , Department of Physician Assistant Studies, College of Allied Health Sciences, 4310N Health Sciences Building, Mail Stop 668, East Carolina University, Greenville, NC 27858-4353, USA; mayerm{at}ecu.edu

Citation

Mayer M
Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the ‘breakthrough’
BMJ Evidence-Based Medicine 2016;21:83-86.

Publication history

  • First published December 30, 2015.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/